❤️ Prasugrel matches ticagrelor on heart risk, less bleeding

The SWITCH SWEDEHEART trial showed prasugrel offers similar cardiovascular event reduction to ticagrelor after coronary stenting. This study was conducted in seven Swedish regions involving 17,095 adults with acute coronary syndromes. Over one year, the primary endpoint of death or major event was 11.1% for prasugrel versus 11.8% for ticagrelor. Crucially, the major bleeding risk was significantly lower with the prasugrel policy at 4.2% compared to 4.4%. This registry-based trial offers pragmatic evidence for clinical decision-making in cardiology.

⚽ Spurs slump continues under De Zerbi 🤔

Tottenham suffered their second consecutive Premier League loss on Saturday, falling 2-0 to Newcastle in their opening home fixture. The match saw Newcastle, who were in good form, climb to third in the league standings. Tottenham created chances, including one by Mathys Tel in the 15th minute, but couldn't score. Newcastle scored first in the 62nd minute via Anthony Elanga and doubled the lead in the 72nd minute with Yoane Wissa. This defeat marks a poor start for Spurs, whose new signing Omar Marmoush debuted in the match.

🏏 Lawrence shines, England extends lead at Lord's

Dan Lawrence scored an unbeaten half-century to help England add 96 runs to their score at Lord's. The team reached 177 for 7 in their second innings, increasing their lead to 357 runs. Play was heavily interrupted by rain on the day, with less than 25 overs completed. Earlier, Emilio Gay was dismissed, and Harry Brook was caught by Mohammad Abbas. Lawrence continued to strike despite the stop-start nature of the batting session. 🏏

🙏 Kashmiri Pandits lay Ram Temple foundation in Shopian

Kashmiri Pandits laid the foundation stone for a Ram Temple at a historic site in Tak Mohalla, Shopian, on Saturday. Hundreds of community members gathered there to perform traditional religious rituals before the event. The shrine at this location was set on fire back in 1989, and the land was later encroached upon. Following administrative efforts, the land has been reclaimed, and construction is set to commence. The Department of Archaeology and Heritage has sanctioned funds for this restoration project.

📦 Amazon makes sellers bid for super fast delivery

Amazon is now asking select third-party sellers in the US to bid for access to its sub-Same Day delivery service. These sellers utilize Fulfillment by Amazon (FBA) and are being asked to pay more for faster shipping options. Currently, eligible orders can reach customers in as little as two hours across 2,300 metropolitan areas. Amazon notes that products in this service have seen 12% higher average sales compared to regular FBA orders. Sellers must now weigh the extra cost against the potential boost in commercial visibility. 🚀

📊 Top Stocks to Watch Before August 31st

Mahindra & Mahindra is expanding its Battery-as-a-Service programme across its Electric Origin SUV lineup. Ola Electric Mobility received a ₹95.81 crore incentive under the PLI scheme from the Ministry of Heavy Industries. NBCC signed an MoU with NHPC for infrastructure projects across India at a 5.5% PMC fee. AXISCADES Technologies approved acquiring a 90% stake in Cloud Wave Technologies for about ₹234 crore. These corporate moves highlight significant developments across various sectors ahead of the end of August. 📈

🦟 Two Die from Malaria After Mosquito Bite at Frankfurt Airport

Two airport workers passed away after contracting malaria from a suspected imported mosquito at Frankfurt Airport. This incident occurred in Germany, where four other employees were hospitalized for treatment. The infections were linked to an Anopheles mosquito brought onto the aircraft, with the event reported on August 30, 2026. Health officials stressed that the risk to the general public remains extremely low, despite the unusual transmission. Authorities are currently examining captured mosquitoes to pinpoint the exact source of these rare cases.

✨ Daily horoscope predictions for August 30, 2026

Aries is blessed by the Moon, suggesting happy vibes and resolution of health issues. Taurus faces a less favorable Moon, warning against risky investments and financial losses. Gemini and Cancer are predicted to have positive professional and personal momentum. Libra might make beneficial decisions, while Scorpio benefits from strong communication skills. Pisces should trust intuition for career growth and financial gains. 🔮

🐕 Dog dispute sparks legal battle on Scottish island

Claire Kellerman has sued a community cafe in Great Bernera after her assistance dog, Tarkina, was refused entry. She is the adopted daughter of Sally Kellerman and moved to the remote Hebridean island in 2023. The legal action was brought under the Equality Act 2010, with the case set for Stornoway Sheriff Court next year. This dispute has created significant financial pressure on two local community organisations involved. Kellerman insists she is being targeted, describing the situation as a 'witch hunt' 🐕.

⚽ Barcelona defender heading to Real Sociedad

FC Barcelona defender Hector Fort is moving to Real Sociedad this season, with an official announcement expected soon. The 20-year-old right-back was seen at Anoeta while finalizing his transfer to the Basque club. Real Sociedad will pay €8.5 million to Barcelona, with the deal set to be confirmed after tonight's match. This move gives FC Barcelona squad space while providing Real Sociedad with new depth. Fort is expected to start training at Zubieta this Sunday.

🔬 New ASCO 2026 guidelines change NSCLC treatment

The ASCO Living Guideline Version 2026.3.3 now emphasizes molecular profiling over just histology for Stage IV NSCLC. Clinicians must now use broad multigene profiling before starting systemic therapy, even if PD-L1 is high. For EGFR mutations, ASCO recommends intensifying frontline therapy with combination options like osimertinib plus platinum-pemetrexed. Furthermore, EGFR exon 20 insertions finally have a true targeted frontline choice with sunvozertinib or platinum-doublet chemotherapy plus amivantamab. These updates shift precision oncology into a more complex, risk-adapted phase. 🔬